GlassScriptPhysician profile
Kimberly Smith
NPI 1023495488
$244.96
in general payments reported to CMS, 2019-2025
12 companies · $66.94 in 2025
The $66.94 reported for 2025 was more than what a typical Nurse Anesthetist, Certified Registered provider received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.09 · 2022: $66.77 · 2023: $46.16 · 2024: $44.00 · 2025: $66.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $29.17 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Braeburn INC. | $26.08 | 2025 | Brixadi |
| Medtronic, INC. | $26.08 | 2022 | |
| Gilead Sciences, INC. | $25.73 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $24.84 | 2023 | Exparel |
| Eagle Pharmaceuticals, INC. | $21.32 | 2023 | |
| Baudax Bio INC. | $21.09 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.64 | 2022 | |
| Ambu INC. | $15.35 | 2022 | |
| Boston Scientific Corporation | $15.13 | 2025 | Clinical Trial Product |
| Lilly USA, LLC | $14.83 | 2024 | Omvoh |
| Micro-Tech Endoscopy USA, INC. | $7.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.